WH Stock Analysis: Wyndham Hotels & Resorts | NYSE
Lodging | NYSE, USA | Market Cap: 5.496m USD | 12M Return: -2.7% | US98311A1051 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 82.4M
EPS Trend: 97.2%
Qual. Beats: 2
Rev. Trend: 73.3%
Qual. Beats: -1
Warnings
Tailwinds
No distinct edge detected
Seasonality 8.4 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Wyndham Hotels & Resorts is the worlds largest hotel franchising company by number of properties, operating approximately 8,300 franchised hotels across roughly 100 countries and six continents. With over 855,000 rooms, the company holds a leading position in the economy and midscale segments of the lodging industry, targeting the everyday traveler.
The company licenses a portfolio of 25 hotel brands, including well-known names such as Super 8, Days Inn, Ramada, Microtel, La Quinta, Baymont, Wingate, AmericInn, ECHO Suites, Registry Collection Hotels, Trademark Collection, and Wyndham. Wyndham Hotels & Resorts was incorporated in 2017 and is headquartered in Parsippany, New Jersey. It trades on the NYSE under the ticker WH and completed its IPO on May 21, 2018.
As a pure-play franchisor, Wyndham operates an asset-light business model that generates revenue primarily from royalty fees, franchise fees, and marketing contributions rather than owning real estate, distinguishing it from integrated hotel operators that own or lease significant property portfolios. It is classified within the GICS Consumer Discretionary sector under Hotels, Resorts & Cruise Lines.
- Asset-light franchise model sustains high-margin royalty revenue growth
- US leisure travel demand drives RevPAR gains in midscale segment
- Travelodge UK acquisition expands European royalty stream and brand footprint
| Net Income: 208.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 0.71 > 1.0 |
| NWC/Revenue: -0.42% < 20% (prev 0.97%; Δ -1.39% < -1%) |
| CFO/TA 0.09 > 3% & CFO 371.0m > Net Income 208.0m |
| Net Debt (2.61b) to EBITDA (495.0m): 5.27 < 3 |
| Current Ratio: 0.99 > 1.5 & < 3 |
| Outstanding Shares: last quarter (75.2m) vs 12m ago -3.59% < -2% |
| Gross Margin: 64.17% > 18% (prev 60.08%; Δ 4.09% > 0.5%) |
| Asset Turnover: 32.86% > 50% (prev 33.69%; Δ -0.83% > 0%) |
| Interest Coverage Ratio: 3.05 > 6 (EBIT TTM 433.0m / Interest Expense TTM 142.0m) |
| A: -0.00 (Total Current Assets 497.0m - Total Current Liabilities 503.0m) / Total Assets 4.33b |
| B: 0.13 (Retained Earnings 568.0m / Total Assets 4.33b) |
| C: 0.10 (EBIT TTM 433.0m / Avg Total Assets 4.32b) |
| D: 0.12 (Book Value of Equity 480.0m / Total Liabilities 3.85b) |
| Altman-Z'' = 1.22 = BB |
| DSRI: 1.06 (Receivables 331.0m/319.0m, Revenue 1.42b/1.45b) |
| GMI: 0.94 (GM 60.08% / 64.17%) |
| AQI: 0.98 (AQ_t 0.85 / AQ_t-1 0.87) |
| SGI: 0.98 (Revenue 1.42b / 1.45b) |
| TATA: -0.04 (NI 208.0m - CFO 371.0m) / TA 4.33b) |
| Beneish M = -3.06 (Cap -4..+1) = AA |
As of October 13, 2026, the stock is trading at USD 73.35 with a total of 767,812 shares traded. Over the past week, the price has changed by +2.99%, over one month by +6.66%, over three months by -4.38% and over the past year by -2.66%.
Current recommended Stop Loss: 70.40 (which is 4% or 1.5 ATR below the current price).
Wyndham Hotels & Resorts has received a consensus analysts rating of 4.41. Therefore, it is recommended to buy WH.
- StrongBuy: 10
- Buy: 4
- Hold: 3
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 97.6 | 33% |
P/E Trailing = 26.5448
P/E Forward = 12.7389
P/S = 3.8759
P/B = 10.7158
P/EG = 0.49
Revenue TTM = 1.42b USD
EBIT TTM = 433.0m USD
EBITDA TTM = 495.0m USD
Long Term Debt = 2.65b USD (from longTermDebt, last quarter)
Short Term Debt = 23.0m USD (from shortTermDebt, last quarter)
Debt = 2.68b USD (from shortLongTermDebtTotal, last quarter) + Leases 3.00m
Net Debt = 2.61b USD (calculated: Debt 2.68b - CCE 69.0m)
Enterprise Value = 8.11b USD (5.50b + Debt 2.68b - CCE 69.0m)
Interest Coverage Ratio = 3.05 (Ebit TTM 433.0m / Interest Expense TTM 142.0m)
EV/FCF = 25.09x (Enterprise Value 8.11b / FCF TTM 323.0m)
FCF Yield = 3.99% (FCF TTM 323.0m / Enterprise Value 8.11b)
FCF Margin = 22.78% (FCF TTM 323.0m / Revenue TTM 1.42b)
Net Margin = 14.67% (Net Income TTM 208.0m / Revenue TTM 1.42b)
Gross Margin = 64.17% ((Revenue TTM 1.42b - Cost of Revenue TTM 508.0m) / Revenue TTM)
Gross Margin QoQ = 91.47% (prev 42.51%)
Tobins Q-Ratio = 1.87 (Enterprise Value 8.11b / Total Assets 4.33b)
Interest Expense / Debt = 5.30% (Interest Expense 142.0m / Debt 2.68b)
Taxrate = 27.78% (80.0m / 288.0m)
NOPAT = 312.7m (EBIT 433.0m * (1 - 27.78%))
Current Ratio = 0.99 (Total Current Assets 497.0m / Total Current Liabilities 503.0m)
Debt / Equity = 5.58 (Debt 2.68b / totalStockholderEquity, last quarter 480.0m)
Debt / EBITDA = 5.27 (Net Debt 2.61b / EBITDA 495.0m)
Debt / FCF = 8.08 (Net Debt 2.61b / FCF TTM 323.0m)
Total Stockholder Equity = 494.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.82% (Net Income 208.0m / Total Assets 4.33b)
RoE = 42.06% (Net Income TTM 208.0m / Total Stockholder Equity 494.5m)
RoCE = 13.76% (EBIT 433.0m / Capital Employed (Equity 494.5m + L.T.Debt 2.65b))
RoIC = 8.27% (NOPAT 312.7m / Invested Capital 3.78b)
WACC = 7.23% (E(5.50b)/V(8.17b) * Re(8.88%) + D(2.68b)/V(8.17b) * Rd(5.30%) * (1-Tc(0.28)))
Discount Rate = 8.88% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -98.25 | Cagr: -3.67%
[DCF] Terminal Value 76.81% ; FCFF base≈309.8m ; Y1≈340.3m ; Y5≈431.4m
[DCF] Fair Price = 53.64 (EV 6.59b - Net Debt 2.61b = Equity 3.98b / Shares 74.2m; r=8.35% [WACC [floored]]; 5y FCF grow 11.38% → 2.50% )
EPS Correlation: 97.21 | EPS CAGR: 8.72% | SUE: 1.15 | # QB: 2
Revenue Correlation: 73.26 | Revenue CAGR: 1.25% | SUE: -2.42 | # QB: -1
EPS current Quarter (2026-09-30): EPS=1.30 | Chg30d=-0.51% | Revisions=-17% | Analysts=14
EPS current Year (2026-12-31): EPS=4.80 | Chg30d=+0.09% | Revisions=+0% | GrowthEPS=+4.7% | GrowthRev=+3.3%
EPS next Year (2027-12-31): EPS=5.33 | Chg30d=-0.29% | Revisions=-17% | GrowthEPS=+11.1% | GrowthRev=+6.2%
[Analyst] Revisions Ratio: -18% (up=3, down=5)